Open access
Jul 2026
An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation
Most patients valued the inclusion of real-world outcome data in the information tool, although many found it challenging to process, and some described the outcome data as overwhelming, underscoring the importance of careful framing and delivery.
E. G. Engelhardt, M. Hackert, Anne Vogelaar et al.
· JMIR Cancer · 0 citations